ConductScience.org, home

Paper32318751

Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment.

Young JW and 3 others. Psychopharmacology (Berl), 2020. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment. Papers, record 32318751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32318751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Young JWJared W
2Roberts BZBenjamin Z
3Breier MMichelle
4Swerdlow NRNeal R

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmphetamineMajor topic
AttentionMajor topic
Central Nervous System StimulantsMajor topic
Choice BehaviorMajor topic
Dopamine AntagonistsMajor topic
HaloperidolMajor topic
Animals
Dose-Response Relationship, Drug
Male
Rats
Rats, Long-Evans
Schizophrenia

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
MH59803NIMH NIH HHSUnited StatesR01MH059803PubMed and NIHNIH RePORTER
DA044909NIH HHSUnited StatesPubMedPubMed
MH94320NIH HHSUnited StatesPubMedPubMed
MH109168NIH HHSUnited StatesPubMedPubMed
T32 NS061847NINDS NIH HHSUnited StatesT32NS061847PubMedNIH RePORTER
DA043535NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117548746Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.Arch Gen Psychiatry2007https://conductscience.org/library/papers/17548746PubMed
225799918Putative therapeutic targets for symptom subtypes of adult ADHD: D4 receptor agonism and COMT inhibition improve attention and response inhibition in a novel translational animal model.Eur Neuropsychopharmacol2015https://conductscience.org/library/papers/25799918PubMed
38297213Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.Arch Gen Psychiatry1994https://conductscience.org/library/papers/8297213PubMed
422080498CNTRICS imaging biomarkers selection: Working memory.Schizophr Bull2012https://conductscience.org/library/papers/22080498PubMed
53108933Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/3108933PubMed
618172017Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.Am J Psychiatry2008https://conductscience.org/library/papers/18172017PubMed
728754432The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species.J Neurosci Methods2017https://conductscience.org/library/papers/28754432PubMed
89844789Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease.Clin Neuropharmacol1998https://conductscience.org/library/papers/9844789PubMed
98197420Impaired attention, genetics, and the pathophysiology of schizophrenia.Schizophr Bull1994https://conductscience.org/library/papers/8197420PubMed
1012373437The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.Psychopharmacology (Berl)2002https://conductscience.org/library/papers/12373437PubMed
1130633928Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention.Neuropharmacology2019https://conductscience.org/library/papers/30633928PubMed
1218451012Impact of the CATIE findings on state mental health policy.Psychiatr Serv2008https://conductscience.org/library/papers/18451012PubMed
1318698321Potential adverse effects of amphetamine treatment on brain and behavior: a review.Mol Psychiatry2009https://conductscience.org/library/papers/18698321PubMed
1417630405Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.Schizophr Bull2007https://conductscience.org/library/papers/17630405PubMed
1524882551Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats.Eur Neuropsychopharmacol2014https://conductscience.org/library/papers/24882551PubMed
1629859849Amphetamine improves mouse and human attention in the 5-choice continuous performance test.Neuropharmacology2018https://conductscience.org/library/papers/29859849PubMed
1729460165Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.Eur Child Adolesc Psychiatry2018https://conductscience.org/library/papers/29460165PubMed
188610818What are the functional consequences of neurocognitive deficits in schizophrenia?Am J Psychiatry1996https://conductscience.org/library/papers/8610818PubMed
1917141755Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians.Eur J Pharmacol2007https://conductscience.org/library/papers/17141755PubMed
2016848689Targeting the dopamine D2 receptor in schizophrenia.Expert Opin Ther Targets2006https://conductscience.org/library/papers/16848689PubMed

See all 74 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42560519Chemogenetic inhibition of the anterior cingulate cortex increases safe decision-making in aged mice performing the Iowa Gambling Task.Psychopharmacology (Berl)2026https://conductscience.org/library/papers/42560519PubMed
42554847Detrimental effects of atomoxetine on visual signal detection in rats: comparison with ADHD psychomotor stimulant drugs.Psychopharmacology (Berl)2026https://conductscience.org/library/papers/42554847PubMed
42481733Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder.Neuropsychopharmacology2026https://conductscience.org/library/papers/42481733PubMed
38302722Sex-specific alterations in cognitive control following moderate prenatal alcohol exposure and transient systemic hypoxia ischemia in the rat.Alcohol Clin Exp Res (Hoboken)2024https://conductscience.org/library/papers/38302722PubMed
37572729Proceedings of the 2022 annual meeting of the Fetal Alcohol Spectrum Disorders study group.Alcohol2023https://conductscience.org/library/papers/37572729PubMed
37217074Impaired cognitive control after moderate prenatal alcohol exposure corresponds to altered EEG power during a rodent touchscreen continuous performance task.Neuropharmacology2023https://conductscience.org/library/papers/37217074PubMed
36434307Theory of visual attention (TVA) applied to rats performing the 5-choice serial reaction time task: differential effects of dopaminergic and noradrenergic manipulations.Psychopharmacology (Berl)2023https://conductscience.org/library/papers/36434307PubMed
35042948EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants.Neuropsychopharmacology2022https://conductscience.org/library/papers/35042948PubMed
33404734Convergent observations of MK-801-induced impairment in rat 5C-CPT performance across laboratories: reversal with a D1 but not nicotinic agonist.Psychopharmacology (Berl)2021https://conductscience.org/library/papers/33404734PubMed
32871507Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence.Drug Alcohol Depend2020https://conductscience.org/library/papers/32871507PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32318751

GET https://conductscience.org/api/papers/v1/32318751/references?page=2